Dotbee.ai

Analysis Sanrhea Technical Textiles Ltd. (SANTETX)

6/4/2024

Analysis Sanrhea Technical Textiles Ltd. (SANTETX)

Analysis of Sanrhea Technical Textiles Ltd. (SANTETX)

Sanrhea Technical Textiles Ltd. has shown some interesting price movements and technical indicators in the recent days:

1. Price Movement:
- The price has been fluctuating between a low of 149.20 and a high of 186.00 in the past 10 days.
- The closing price on the latest available date was 161.60, which is closer to the lower end of the price range.

2. Relative Strength Index (RSI):
- The RSI values have been fluctuating between 52.22 and 85.98, indicating some volatility in the stock.
- The RSI value on the latest available date was 57.31, suggesting a moderate level of buying momentum.

3. Moving Average Convergence Divergence (MACD):
- The MACD indicator has been positive in the recent days, with the MACD line consistently above the signal line.
- The MACD histogram has shown some fluctuations but has generally remained positive, indicating a bullish trend.

4. Moving Averages (MA):
- The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have all been trending upwards, suggesting a positive momentum in the stock price.

Overall, based on the technical indicators, Sanrhea Technical Textiles Ltd. appears to be in a bullish phase with positive momentum. However, investors should closely monitor the price movements and key technical indicators for any potential changes in the trend.

Earnings

The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.

Main Statystic 🧠

The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.

In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.

Looking at stock statistics, the company has a relatively low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.

Valuation metrics show a high PEG ratio and price-to-book ratio, indicating potentially overvalued stock. The company's market capitalization and enterprise value are substantial, with moderate price-to-sales and enterprise-to-EBITDA ratios.

The stock price summary includes beta, moving averages, and the range of prices over the past year. Dividends and splits information shows the company's dividend history, payout ratio, and dividend yield metrics.

Income statement 💸

These are the revenue figures. Here are the conclusions:

1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, suggesting efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, indicating overall profitability growth.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to maintain a healthy EBITDA margin, reflecting strong operational performance.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.

Balance Sheet

These are balance sheets. Here are the conclusions based on the provided data:

1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. Current assets fluctuate from year to year, with the highest value of $162,819,000,000 in 2019.
3. Non-current assets have shown an increasing trend, with the peak value of $234,386,000,000 in 2018.
4. Total liabilities have also been increasing, reaching the highest value of $302,083,000,000 in 2022.
5. Shareholders' equity has shown variations over the years, with the highest value of $107,147,000,000 in 2018.
6. The company has been relying more on non-current assets to finance its operations, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been financing its operations through a mix of equity and liabilities, with fluctuations in the proportions of each over the years.

Cash Flow 💶

This is the cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.

Earnings estimate

Based on the analysts' estimates for future quarterly and annual earnings per share:

1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.

2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.

3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.

4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the previous year.

Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.

Revenue estimate

Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:

1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.

2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.

3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.

4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.

Growth estimates

Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:

1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.

These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still expected to be healthy.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD

Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, indicating that analysts generally expect the price to increase in the future. However, it's important to note that these are just forecasts and actual market conditions may vary.

MACD of SANTETX

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link